Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year results.

BACKGROUND: Pegylated liposomal doxorubicin (PLD) is a liposome-encapsulated form of doxorubicin with equivalent efficacy and less cardiotoxicity. This phase 2 study evaluated the efficacy and safety of the PLD-containing CHOP regimen in newly diagnosed patients with aggressive peripheral T-cell lymphomas (PTCL). METHODS: Patients received PLD, cyclophosphamide, vincristine/vindesine, plus prednisone every 3 weeks for up to 6 cycles. The primary endpoint was the objective response rate at the end of treatment (EOT). RESULTS: From September 2015 to January 2017, 40 patients were treated. At the EOT, objective response was achieved by 82.5% of patients, with 62.5% complete response. As of the cutoff date (September 26, 2023), median progression-free survival (mPFS) and overall survival (mOS) were not reached (NR). The 2-year, 5-year, and 8-year PFS rates were 55.1%, 52.0%, and 52.0%. OS rate was 80.0% at 2 years, 62.5% at 5 years, and 54.3% at 8 years. Patients with progression of disease within 24 months (POD24) had worse prognosis than those without POD24, regarding mOS (41.2 months vs NR), 5-year OS (33.3% vs 94.4%), and 8-year OS (13.3% vs 94.4%). Common grade 3-4 adverse events were neutropenia (87.5%), leukopenia (80.0%), anemia (17.5%), and pneumonitis (17.5%). CONCLUSION: This combination had long-term benefits and manageable tolerability, particularly with less cardiotoxicity, for aggressive PTCL, which might provide a favorable benefit-risk balance. CLINICALTRIALS.GOV IDENTIFIER: Chinese Clinical Trial Registry, ChiCTR2100054588; IRB Approved: Ethics committee of Fudan University Shanghai Cancer Center (Date 2015.8.31/No. 1508151-13.

[Comparison of the Diagnostic Values of Dynamic Enhanced Magnetic Resonance Imaging,Digital Breast Tomosynthesis,and Digital Mammography for Early Breast Cancer].

Objective To compare the values of dynamic enhanced magnetic resonance imaging(DCE-MRI),digital breast tomosynthesis(DBT),and digital mammography(DM)in the early detection and diagnosis of breast cancer.Methods We retrospectively analyzed the clinical and imaging data of 65 cases with early breast cancer confirmed by surgical pathology from June 2017 to December 2018.All patients underwent breast DCE-MRI,DM and DBT before surgery.The receiver operating characteristic(ROC)curves were drawn,with the pathological results as the gold standard,to evaluate the diagnostic performance of different examination methods.The areas under ROC curves(AUCs)were compared using Z test.The differences among DCE-MRI,DBT and DM in detecting early breast cancer were compared using chi-square test in terms of positive rates,accuracy,sensitivity,and specificity.Pearson correlation analysis was performed to assess the accuracy of these imaging methods in detecting the size of early breast cancer.Results The AUCs of DCE-MRI,DBT,and DM based on the BI-RADS classification for early diagnosis of breast cancer were 0.910,0.832,and 0.700,respectively(z=2.132,P=0.001);the sensitivity of DCE-MRI,DBT,and DM for early breast cancer was 92.3%,70.8%,and 52.5%,the specificity was 65.0%,85.0%,and 79.3%,and the accuracy was 83.1%,70.8%,and 50.8%,indicating that DCE-MRI(χ 2=15.330,P=0.0001) and DBT(χ 2=5.450,P=0.020) had significantly higher diagnostic accuracy than DM.The measurement results of DM,DBT,and DCE-MRI were positively correlated with the pathological measurements(r=0.781,r=0.847,r=0.946;all P<0.01). Conclusions DCE-MRI and DBT have higher positive rates and accuracies than DM in detecting early breast cancer.Medical institutions where DCE-MRI is still not available can use DBT to improve the early detection of breast cancer.

[Stretched-exponential and mono-exponential diffusion-weighted imaging for assessing the aggressiveness of prostate cancer: A histogram analysis].

OBJECTIVE: To assess the value of stretched-exponential and mono-exponential diffusion-weighted imaging (DWI) in predicting the aggressiveness of PCa. METHODS: This retrospective study included 36 cases of PCa with 48 lesions in the peripheral zone diagnosed by DWI with b-values of 0, 500, 1000, and 2000 s/mm2. We reconstructed the apparent diffusion coefficient (ADC), distributed diffusion coefficient (DDC) and α maps on the post-processing workstation, performed a histogram analysis on the largest slice of PCa on T2WI and Spearman's rank-order analysis on the correlation of the histogram variables with Gleason grade grouping (GG). Then, we assessed the values of the histogram variables in differentiating low-grade from high-grade PCa using the receiver operating characteristic (ROC) curve. RESULTS: The percentile and mean ADCs and DDCs were correlated with GG (ρ: 0.392－0.641) but not the α value, skewnesses and kurtosises (ρ: 0.055－0.266). High-grade PCa exhibited significantly lower 10th-, 25th-, 50th- and 75th-percentile and mean ADCs (490 ± 141, 591 ± 137, 695 ± 137, 781 ± 139 and 888 ± 135 mm2/s) and DDCs (420 ± 146, 534 ± 167, 666 ± 182, 787 ± 190 and 912 ± 175 mm2/s) than low-grade PCa (ADCs: 636 ± 74, 727 ± 86, 825 ± 85, 907 ± 85 and 975 ± 117 mm2/s; DDCs: 542 ± 80, 666 ± 93, 806 ± 108, 910 ± 110 and 1023 ± 105 mm2/s), but there were no statistically significant differences between low- and high-grade PCa in the α value (0.67 ± 0.042 vs 0.64 ± 0.036), kurtosises (ADC 0.105 vs 0.078; DDC －0.027 vs －0.401) or skewnesses (ADC －0.042 vs 0.067; DDC －0.058 vs 0.162). Both 10th-percentile ADCs and DDCs showed a higher efficiency than the mean ones in differentiating high- from low-grade PCa, though with no statistically significant difference (P > 0.05). CONCLUSIONS: Histogram variables DDCs and ADCs, rather than the α value, can be used to predict the aggressiveness of PCa, even more efficiently at the 10th percentile than on the mean.

[Evaluation of Uterine Tumor Angiogenesis with Quantitative Magnetic Resonance Imaging Perfusion Parameters].

The development and metastasis of uterine tumors depend highly on tumor angiogenesis. Multiphase dynamic contrast-enhanced magnetic resonance imaging can quantitatively describe the hemodynamic changes of uterine tumors based on a variety of tracer kinetic models and time-signal curves and by simulating the distribution of contrast inside and outside the blood vessels. Functional parameters can accurately and noninvasively assess tumor angiogenesis. It provides a non-invasive functional evaluation method for the differential diagnosis,staging,response evaluation,and prognostic prediction of uterine tumors.

Electroacupuncture prevents cognitive impairments by regulating the early changes after brain irradiation in rats.

Cognitive impairments severely affect the quality of life of patients who undergo brain irradiation, and there are no effective preventive strategies. In this study, we examined the therapeutic potential of electroacupuncture (EA) administered immediately after brain irradiation in rats. We detected changes in cognitive function, neurogenesis, and synaptic density at different time points after irradiation, but found that EA could protect the blood-brain barrier (BBB), inhibit neuroinflammatory cytokine expression, upregulate angiogenic cytokine expression, and modulate the levels of neurotransmitter receptors and neuropeptides in the early phase. Moreover, EA protected spatial memory and recognition in the delayed phase. At the cellular/molecular level, the preventative effect of EA on cognitive dysfunction was not dependent on hippocampal neurogenesis; rather, it was related to synaptophysin expression. Our results suggest that EA applied immediately after brain irradiation can prevent cognitive impairments by protecting against the early changes induced by irradiation and may be a novel approach for preventing or ameliorating cognitive impairments in patients with brain tumors who require radiotherapy.

Rectal gastrointestinal stromal tumors: imaging features with clinical and pathological correlation.

AIM: To investigate computed tomography (CT) and magnetic resonance imaging (MRI) manifestations of rectal gastrointestinal stromal tumors (GISTs) in order to enhance the recognition of these rare tumors. METHODS: Fourteen patients with pathologically proven rectal GISTs were retrospectively reviewed. Patient histories were retrospectively reviewed for patient age, gender, presenting symptoms, endoscopic investigations, operation notes and pathologic slides. All tumors were evaluated for CD117, CD34 expression, and the tumors were stratified according to current criteria of the National Institutes of Health (NIH). In all cases the first pre-operation imaging findings (CT and MRI, n = 3; MRI only, n = 8; CT only, n = 3) were analyzed by two experienced radiologists by consensus, which include: tumor size, shape, CT density (hypodense, isodense and hyperdense), MRI signal intensity (hypointense, isointense and hyperintense), epicenter (intraluminal or extraluminal), margin (well-defined or ill-defined), internal component (presence of calcifications, necrosis, hemorrhage or ulceration), pattern and degree of enhancement, invasion into adjacent structures. After review of the radiologic studies, clinical and pathological findings were correlated with radiological findings. RESULTS: The patients, 13 men and 1 woman, were aged 31-62 years (mean = 51.5 ± 10.7 years). The most common initial presentation was hematochezia (n = 6). The mean tumor diameter was 5.68 ± 2.64 cm (range 1.5-11.2 cm). Eight lesions were round or oval, and 6 lesions were irregular. Eleven lesions were well-defined and 3 had ill-defined margins. Ten tumors were extraluminal and 4 were intraluminal. The density and MR signal intensity of the solid component of the lesions were similar to that of muscle on unenhanced CT (n = 6) and T1-weighted images (n = 11), and hyperintense on T2-weighted MR images. Calcification was detected in 2 tumors. Following intravenous injection of contrast media, 3 lesions had mild enhancement and 11 lesions had moderate enhancement. Enhancement was homogenous in 3 lesions and heterogeneous in 11. In 1 of 11 patients who underwent both CT and MRI, the tumor was homogenous on CT scan and heterogeneous on MRI. Eight patients were classified as high risk according to the modified recurrent risk classification system of NIH. CONCLUSION: Rectal GISTs usually manifest as large, well-circumscribed, exophytic masses with moderate and heterogeneous enhancement on CT and MRI. The invasion of adjacent organs, bowel obstruction and local adenopathy are uncommon.

Implications for preserving neural stem cells in whole brain radiotherapy and prophylactic cranial irradiation: a review of 2270 metastases in 488 patients.

This study delineated the incidence of metastatic involvement of neural stem cell (NSC) regions and further aimed to explore the feasibility of selectively sparing the NSC compartments during whole brain radiotherapy (WBRT) and prophylactic cranial irradiation (PCI). A total of 2270 intracranial metastases in 488 patients were identified. Lesions were classified according to locations, including lesions in the NSC compartments (subventricular zone, SVZ, or hippocampus) and those in the rest of the brain/brainstem. The incidence of involvement of NSC regions was compared between oligometastatic patients (those with 1-4 lesions) and non-oligometastatic patients (those with 5 or more lesions) using a chi-square test. The volume of the NSC regions accounted for 2.23% of the whole brain, and the overall rate of metastatic lesions in NSC regions was 1.1% in 2270 metastases (25/2270), and 4.7% in 488 patients (23/488). Of the NSC region metastases, 7 (0.3%) involved the hippocampus and 18 (0.8%) occurred in the SVZ. Among the 7 hippocampal metastases identified in this study, 1/7 (14.3%) were found in oligometastatic patients, while 6/7 (85.7%) metastases were in non-oligometastatic patients. For metastases in the SVZ, all lesions occurred in non-oligometastatic patients with none in oligometastatic patients. Metastatic involvement of the NSC compartments was significantly lower in oligometastatic patients (0.15%, 1/670) than in non-oligometastatic patients (1.5%, 24/1600) (P < 0.001). Our retrospective review of 2270 metastases in 488 patients is that the volume of the compartments of NSC regions was 2.23% relative to the whole brain, but the incidence of involvement of the NSC compartments was 1.1%, and the vast majority of NSC lesions were found in non-oligometastatic patients. We believe our data supports selective reduction of doses for these aforementioned structures, when treating oligometastatic patients with WBRT and locally advanced-stage small-cell lung cancer patients with PCI.

[Fast 3D surface rendering for CT or MR image on a personal computer].

Objective. To design a 3D surface reconstruction algorithm capable of reconstructing 3D shapes of the organs, bones and tissues rapidly from CT or MR image on a personal computer. Method. By transforming and decomposing the projection of the discrete 3D data field into shear transformation and warp transformation, a Shear-Warp algorithm realizing the 3D reconstruction was established. The algorithm reduce the amount of computation obviously. The 3D surface was reconstructed by using the principle of the parallel projection, basing on the Shear-Warp algorithm. Shear transformation was performed on the volume data at first. Then the warped 3D surface was obtained by making a threshold in the sheared space. The brightness of the 3D surface was calculated using Phong brightness model, and the final image was generated through the Warp transformation. Result. A direct 3D surface reconstruction algorithm was established basing on a principle of projection from the Shear-Warp algorithm, which was able to display 3D surface on a personal computer rapidly. Conclusion. Compared with other surface reconstruction algorithms, the proposed algorithm has the advantages of no preprocessing, no intermediate data are generated in the reconstruction. With this new algorithm, it is possible to realize fast 3D surface rendering for medical images on a personal computer without the support of any hardware accelerator.